Gene · 8744
Papers3,166
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 3,166
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Next-generation antigen-presenting cell immune therapeutics for gliomas. | J Clin Invest | 2023 | 36719372 | PubTator, text mining | PubMed |
| ANXA10 is a prognostic biomarker and suppressor of hepatocellular carcinoma: a bioinformatics analysis and experimental validation. | Sci Rep | 2023 | 36709331 | PubTator, text mining | PubMed |
| Single-cell dissection of cellular and molecular features underlying human cervical squamous cell carcinoma initiation and progression. | Sci Adv | 2023 | 36706185 | PubTator, text mining | PubMed |
| 4-1BB and cytokines trigger human NK, γδ T, and CD8+ T cell proliferation and activation, but are not required for their effector functions. | Immun Inflamm Dis | 2023 | 36705415 | PubTator, text mining | PubMed |
| Expanded NK cells used for adoptive cell therapy maintain diverse clonality and contain long-lived memory-like NK cell populations. | Mol Ther Oncolytics | 2023 | 36699615 | PubTator, text mining | PubMed |
| Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolution. | Mol Cancer | 2023 | 36691028 | PubTator, text mining | PubMed |
| The Upregulation of GSTO2 is Associated with Colon Cancer Progression and a Poor Prognosis. | J Oncol | 2023 | 36688005 | PubTator, text mining | PubMed |
| Computational analyses of the interactome between TNF and TNFR superfamilies. | Comput Biol Chem | 2023 | 36682326 | PubTator, text mining | PubMed |
| African Swine Fever Virus Infection and Cytokine Response In Vivo: An Update. | Viruses | 2023 | 36680273 | PubTator, text mining | PubMed |
| Exploring Mast Cell-CD8 T Cell Interactions in Inflammatory Skin Diseases. | Int J Mol Sci | 2023 | 36675078 | PubTator, text mining | PubMed |
| The Importance of the Immune System and Molecular Cell Signaling Pathways in the Pathogenesis and Progression of Lung Cancer. | Int J Mol Sci | 2023 | 36675020 | PubTator, text mining | PubMed |
| Extracellular Vesicles-Based Cell-Cell Communication in Melanoma: New Perspectives in Diagnostics and Therapy. | Int J Mol Sci | 2023 | 36674479 | PubTator, text mining | PubMed |
| An Aggrephagy-Related LncRNA Signature for the Prognosis of Pancreatic Adenocarcinoma. | Genes (Basel) | 2023 | 36672865 | PubTator, text mining | PubMed |
| Development and validation of a novel ferroptosis‑related lncRNA prognostic signature for pancreatic adenocarcinoma. | Mol Med Rep | 2023 | 36660936 | PubTator, text mining | PubMed |
| Genetic lesions and targeted therapy in Hodgkin lymphoma. | Ther Adv Hematol | 2023 | 36654739 | PubTator, text mining | PubMed |
| Prognostic costimulatory molecule-related signature risk model correlates with immunotherapy response in colon cancer. | Sci Rep | 2023 | 36646765 | PubTator, text mining | PubMed |
| Oral Microbiota Alteration and Roles in Epstein-Barr Virus Reactivation in Nasopharyngeal Carcinoma. | Microbiol Spectr | 2023 | 36645283 | PubTator, text mining | PubMed |
| Integrated analysis of single-cell RNA-seq and bulk RNA-seq unveils heterogeneity and establishes a novel signature for prognosis and tumor immune microenvironment in ovarian cancer. | J Ovarian Res | 2023 | 36642706 | PubTator, text mining | PubMed |
| Multi-omics characterization of a scoring system to quantify hypoxia patterns in patients with head and neck squamous cell carcinoma. | J Transl Med | 2023 | 36627705 | PubTator, text mining | PubMed |
| Cell Pair Algorithm-Based Immune Infiltrating Cell Signature for Improving Outcomes and Treatment Responses in Patients with Hepatocellular Carcinoma. | Cells | 2023 | 36611994 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8744/papers?page=30